Top

Published in:

01-01-2015 | Original Communication

Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2

Authors: Stojan Peric, Gorana Mandic-Stojmenovic, Elka Stefanova, Dusanka Savic-Pavicevic, Jovan Pesovic, Vera Ilic, Valerija Dobricic, Ivana Basta, Dragana Lavrnic, Vidosava Rakocevic-Stojanovic

Published in: Journal of Neurology | Issue 1/2015

Abstract

The aim of this study was to assess cognitive status in a large group of patients with myotonic dystrophy type 2 (DM2) compared to type 1 (DM1) subjects matched for gender and age, using a comprehensive battery of neuropsychological tests. Thirty-four genetically confirmed adult DM2 patients were recruited and matched for gender and age with 34 adult-onset DM1 subjects. All patients underwent detailed classic pen and pencil neuropsychological investigation and also computerized automated battery—CANTAB. More than half of DM2 patients had abnormal results on executive tests [Intra/Extradimensional Set Shift (IED), Stockings of Cambridge (SOC)] and verbal episodic memory (Ray Auditory Verbal Learning Test). Regarding DM1, abnormal results in more than 50 % of subjects were achieved in even ten tests, including visuospatial, language, executive, cognitive screening and visual memory tests. Direct comparison between patient groups showed that lower percentage of DM2 patients had abnormal results on following tests: Addenbrooke’s Cognitive Examination—Revised, Raven Standard Progressive Matrices, Block Design, copy and recall of Rey-Osterieth Complex Figure, number of categories and perseverative responses on Wisconsin Card Sorting Test and Boston Naming Test (p < 0.01), as well as Trail Making Test—B and Spatial Span (p < 0.05). Our results showed significant dysexecutive syndrome and certain impairment of episodic verbal memory in DM2 patients that are reflective of frontal (especially frontostriatal) and temporal lobe dysfunction. On the other hand, dysexecutive and visuospatial/visuoconstructional deficits predominate in DM1 which correspond to the frontal, parietal (and occipital) lobe dysfunction.

Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11(10):891–905CrossRefPubMed

de León MB, Cisneros B (2008) Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms. J Neurosci Res 86(1):18–26CrossRefPubMed

Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N (2005) Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65(10):1636–1638CrossRefPubMed

Ono S, Inoue K, Mannen T, Mitake S, Shirai T, Kanda F, Jinnai K, Takahashi K (1989) Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathol 77(4):350–356CrossRefPubMed

Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, Mitake S, Inagaki T, Yamano T, Nagao K (1998) Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 50(2):535–538CrossRefPubMed

Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H et al (1996) Tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711–717CrossRefPubMed

Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I, Kashima H (2006) Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 26(2):107–114CrossRefPubMed

Antonini G, Mainero C, Romano A, Giubilei F, Ceschin V, Gragnani F, Morino S, Fiorelli M, Soscia F, Di Pasquale A, Caramia F (2004) Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry 75(11):1611–1613PubMedCentralCrossRefPubMed

Weber YG, Roebling R, Kassubek J, Hoffmann S, Rosenbohm A, Wolf M, Steinbach P, Jurkat-Rott K, Walter H, Reske SN, Lehmann-Horn F, Mottaghy FM, Lerche H (2010) Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 74(14):1108–1117CrossRefPubMed

10.

Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(12):3530–3546CrossRefPubMed

11.

Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schröder R (2004) Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 251(6):710–714CrossRefPubMed

12.

Romeo V, Pegoraro E, Ferrati C, Squarzanti F, Sorarù G, Palmieri A, Zucchetta P, Antunovic L, Bonifazi E, Novelli G, Trevisan CP, Ermani M, Manara R, Angelini C (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257(8):1246–1255CrossRefPubMed

13.

Fukuda H, Horiguchi J, Ono C, Ohshita T, Takaba J, Ito K (2005) Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 46(1):104–109CrossRefPubMed

14.

Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG (2003) Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 348(2):73–76CrossRefPubMed

15.

Minnerop M, Luders E, Specht K, Ruhlmann J, Schneider-Gold C, Schröder R, Thompson PM, Toga AW, Klockgether T, Kornblum C (2008) Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2. J Neurol 255(12):1904–1909PubMedCentralCrossRefPubMed

16.

Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22(6):483–491PubMedCentralCrossRefPubMed

17.

Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, Fazio F, Thornton CA, Moxley RT (1999) Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 53(5):1042–1050CrossRefPubMed

18.

Chang L, Anderson T, Migneco OA, Boone K, Mehringer CM, Villanueva-Meyer J, Berman N, Mena I (1993) Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 50(9):917–923CrossRefPubMed

19.

Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 13(10):813–821CrossRefPubMed

20.

Gaul C, Schmidt T, Windisch G, Wieser T, Müller T, Vielhaber S, Zierz S, Leplow B (2006) Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology 67(2):350–352CrossRefPubMed

21.

Modoni A, Silvestri G, Pomponi MG, Mangiola F, Tonali PA, Marra C (2004) Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 61:1943–1947CrossRefPubMed

22.

Winblad S, Lindberg C, Hansen S (2006) Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2:16PubMedCentralCrossRefPubMed

23.

Sansone V, Gandossini S, Cotelli M, Calabria M, Zanetti O, Meola G (2007) Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol Sci 28(1):9–15CrossRefPubMed

24.

Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H (2012) Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 20(12):1203–1208PubMedCentralCrossRefPubMed

25.

Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56:336–340CrossRefPubMed

26.

Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85(7):399–402PubMedCentralPubMed

27.

Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed

28.

Burke H (1985) Raven Progressive Matrices: more on norms, reliability, and validity. J Clin Psychol 41:231–235CrossRef

29.

Pavlovic D (2003) Dijagnosticki testovi u neuropsihologiji, II edn. Grafos, Beograd

30.

Geffen G, Hoar KJ, O’Hanlon AP, Clark CR, Geffen LB (1990) Performance measures of 16- to 86-year-old males and females on the Auditory Verbal Learning Test. Clin Neuropsychol 4:45–63CrossRef

31.

Spreen O, Strauss E (1991) A compendium of neuropsychological tests. Administration, norms and commentary, Oxford University Press, New York

32.

Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders. Lea and Febiger, Philadelphia

33.

Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36:294–306CrossRefPubMed

34.

http://www.cambridgecognition.com/tests/intra-extra-dimensional-set-shift-ied. Accessed 16 Aug 2014

35.

Chu K, Cho JW, Song EC, Jeon BS (2002) A patient with proximal myotonic myopathy and parkinsonism. Can J Neurol Sci 29(2):188–190PubMed

36.

Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Cotelli M, Vitelli E (2006) Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 77(3):425–426PubMedCentralCrossRefPubMed

37.

Annic A, Devos D, Destée A, Defebvre L, Lacour A, Hurtevent JF, Stojkovic T (2008) Early dopasensitive Parkinsonism related to myotonic dystrophy type 2. Mov Disord 23(14):2100–2101PubMed

38.

Lim SY, Wadia P, Wenning GK, Lang AE (2009) Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord 24(9):1407–1409CrossRefPubMed

39.

Bugiardini E (2014) Meola G; DM-CNS Group. Consensus on cerebral involvement in myotonic dystrophy: workshop report: May 24-27, 2013, Ferrere (AT), Italy. Neuromuscul Disord 24(5):445–452CrossRefPubMed

40.

Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, Ruberto A, Tatarelli R (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38(3):181–185CrossRefPubMed

41.

Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V, Basta I, Nikolic A, Stefanova E (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 126C:76–81CrossRef

Title: Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2
Authors: Stojan Peric
Gorana Mandic-Stojmenovic
Elka Stefanova
Dusanka Savic-Pavicevic
Jovan Pesovic
Vera Ilic
Valerija Dobricic
Ivana Basta
Dragana Lavrnic
Vidosava Rakocevic-Stojanovic
Publication date: 01-01-2015
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 1/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7545-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Ataxia and tremor due to lesions involving cerebellar projection pathways: a DTI tractographic study in six patients

Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome

Post-stroke depression and lesion location: a systematic review

Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report

Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies

Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature